日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ataxin-2 as a candidate blood biomarker for estimating disease status in cases of suspected glioblastoma recurrence

Ataxin-2 作为评估疑似胶质母细胞瘤复发病例疾病状态的候选血液生物标志物

Garaeva, Farida; Nakajima, Riho; Tamai, Sho; Tateishi, Kensuke; Mukasa, Akitake; Kawabata, Shinji; Nagashima, Hiroaki; Natsumeda, Manabu; Hirai, Nozomi; Tanaka, Shota; Ohba, Shigeo; Higa, Nayuta; Arakawa, Yoshiki; Kondo, Akihide; Kohzuki, Hidehiro; Koizumi, Shinichiro; Fujioka, Yutaka; Abe, Tatsuya; Sabit, Hemragul; Kinoshita, Masashi; Uchida, Yasuo; Ohtsuki, Sumio; Nakada, Mitsutoshi

EphrinA2 promotes glioma cell migration and invasion through EphA2 and FAK.

EphrinA2 通过 EphA2 和 FAK 促进胶质瘤细胞的迁移和侵袭

Hirai Nozomi, Tamai Sho, Ichinose Toshiya, Sabit Hemragul, Saito Norihiko, Iwabuchi Satoshi, Nakada Mitsutoshi

Recurrence of an extracranial internal carotid artery aneurysm treated with STA-MCA bypass and trapping due to neovascularization from an ascending pharyngeal artery: illustrative case

颅外段颈内动脉瘤复发,经颞浅动脉-大脑中动脉搭桥术治疗后,因咽升动脉新生血管形成导致动脉瘤夹闭:病例报告

Shomura, Keijiro; Kamide, Tomoya; Uno, Takehiro; Misaki, Kouichi; Nakada, Satoko; Ito, Yukinobu; Sabit, Hemragul; Yoshikawa, Akifumi; Mohri, Masanao; Uchiyama, Naoyuki; Nakada, Mitsutoshi

Therapeutic potential of pentamidine for glioma-initiating cells and glioma cells through multimodal antitumor effects

喷他脒通过多模式抗肿瘤作用对胶质瘤起始细胞和胶质瘤细胞的治疗潜力

Tamai, Sho; Ichinose, Toshiya; Jiapaer, Shabierjiang; Hirai, Nozomi; Sabit, Hemragul; Tanaka, Shingo; Kinoshita, Masashi; Kobayashi, Masahiko; Hirao, Atsushi; Nakada, Mitsutoshi

Tumor Microenvironment in Glioma Invasion

胶质瘤侵袭中的肿瘤微环境

Tamai, Sho; Ichinose, Toshiya; Tsutsui, Taishi; Tanaka, Shingo; Garaeva, Farida; Sabit, Hemragul; Nakada, Mitsutoshi

PATH-37. PROGNOSTIC ROLE OF TERT PROMOTER MUTATIONS IMPROVES THE STRATIFICATION OF IDH-MUTATED LOWER GRADE GLIOMA

PATH-37. TERT启动子突变的预后作用可改善IDH突变型低级别胶质瘤的分层

Hoz, Samer S; Al-Sharshahi, Zahraa F; Alrawi, Mohammed A; Al-Dhahir, Mohammed A; Arita, Hideyuki; Matsushita, Yuko; Ohno, Makoto; Miyake, Yohei; Saito, Kuniaki; Tanaka, Shota; Nakamura, Taishi; Tamura, Kaoru; Higuchi, Fumi; Sandika, Eriel; Sabit, Hemragul; Hattori, Yasuhiko; Yamaguchi, Shigeru; Okita, Yoshiko; Sakamoto, Daisuke; Fukai, Junya; Uda, Takehiro; Hata, Nohuhiro; Shofuda, Tomoko; Sasayama, Takashi; Mori, Kanji; Kurozumi, Kazuhiko; Kanamori, Masayuki; Sasaki, Hikaru; Kishima, Haruhiko; Kanemura, Yonehiro; Nakada, Mitsutoshi; Sonoda, Yukihiko; Nagane, Motoo; Ueki, Keisuke; Nishikawa, Ryo; Narita, Yoshitaka; Ichimura, Koichi

Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma

受体酪氨酸激酶AXL的激活调节胶质母细胞瘤的免疫微环境

Sadahiro, Hirokazu; Kang, Kyung-Don; Gibson, Justin T; Minata, Mutsuko; Yu, Hai; Shi, Junfeng; Chhipa, Rishi; Chen, Zhihong; Lu, Songjian; Simoni, Yannick; Furuta, Takuya; Sabit, Hemragul; Zhang, Suojun; Bastola, Soniya; Yamaguchi, Shinobu; Alsheikh, Hebaallah; Komarova, Svetlana; Wang, Jun; Kim, Sung-Hak; Hambardzumyan, Dolores; Lu, Xinghua; Newell, Evan W; DasGupta, Biplab; Nakada, Mitsutoshi; Lee, L James; Nabors, Burt; Norian, Lyse A; Nakano, Ichiro

Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma

糖原合成酶激酶-3β靶向药物重定位治疗胶质母细胞瘤的生物学基础和临床研究

Furuta, Takuya; Sabit, Hemragul; Dong, Yu; Miyashita, Katsuyoshi; Kinoshita, Masashi; Uchiyama, Naoyuki; Hayashi, Yasuhiko; Hayashi, Yutaka; Minamoto, Toshinari; Nakada, Mitsutoshi

Volumetric growth analysis of an insular dysembryoplastic neuroepithelial tumor over a 10-year follow-up

对岛叶胚胎发育不良性神经上皮肿瘤进行10年随访期间的体积增长分析

Uno, Takehiro; Kinoshita, Masashi; Furuta, Takuya; Miyashita, Katsuyoshi; Sabit, Hemragul; Nakada, Mitsutoshi

CS-25: MOLECULAR SUBCLASSIFICATION OF GLIOBLASTOMA BASED ON THE ABSOLUTE QUANTITATIVE PROTEOMICS

CS-25:基于绝对定量蛋白质组学的胶质母细胞瘤分子亚分类

Bumpus, Stefanie B; Kelleher, Neil L; Nakada, Mitsutoshi; Obuchi, Wataru; Ohtsuki, Sumio; Tanaka, Shingo; Furuta, Takuya; Kitabayashi, Tomohiro; Sabit, Hemragul; Terasaki, Tetsuya; Hayashi, Yutaka